E551-0326 Screening compound: N-[2-(6-{[(2-chlorophenyl)methyl]sulfanyl}-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)ethyl]-4-methoxybenzene-1-sulfonamide

E551-0326 Screening compound: N-[2-(6-{[(2-chlorophenyl)methyl]sulfanyl}-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)ethyl]-4-methoxybenzene-1-sulfonamide
E551-0326 Screening compound: N-[2-(6-{[(2-chlorophenyl)methyl]sulfanyl}-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)ethyl]-4-methoxybenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E551-0326
N-[2-(6-{[(2-chlorophenyl)methyl]sulfanyl}-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)ethyl]-4-methoxybenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E551-0326

Molecular Formula

C21H20ClN5O3S2 (C21 H20 ClN5 O3 S2)

Compound Name

N-[2-(6-{[(2-chlorophenyl)methyl]sulfanyl}-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)ethyl]-4-methoxybenzene-1-sulfonamide

IUPAC name

N-[2-(6-{[(2-chlorophenyl)methyl]sulfanyl}-[124]triazolo[43-b]pyridazin-3-yl)ethyl]-4-methoxybenzene-1-sulfonamide

SMILES

COc(cc1)ccc1S(NCCc1nnc(cc2)n1nc2SCc(cccc1)c1Cl)(=O)=O

InChI

InChI=1S/C21H20ClN5O3S2/c1-30-16-6-8-17(9-7-16)32(28,29)23-13-12-20-25-24-19-10-11-21(26-27(19)20)31-14-15-4-2-3-5-18(15)22/h2-11,23H,12-14H2,1H3

InChI Key

IUVOCZQPEMJLLZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD05897290

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

490.01

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.838

Distribution Coefficient, logD

3.838

Water Solubility, LogSw

-4.12

Polar Surface Area

81.878

Acid Dissociation Constant (pKa)

10.81

Base Dissociation Constant (pKb)

1.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.00

E551-0326 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with E551-0326 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E551-0326?
Check Price and Availability of E551-0326, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E551-0326 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E551-0326
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E551-0326
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E551-0326 available by request